SEQUENTIAL CHANGES IN CIRCULATING LEVELS OF ANGIOTENSIN I AND II, RENIN, AND BRADYKININ AFTER CAPTOPRIL
- 1 October 1979
- journal article
- research article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 2 (SP2)
- https://doi.org/10.5694/j.1326-5377.1979.tb127300.x
Abstract
Venous blood levels of angiotensin I, angiotensin II, bradykinin and renin were measured before, and 30, 60, 90 and 120 minutes after, the administration of Captopril (50 mg) to eight normal subjects. Similar measurements were made in a patient with proved renovascular hypertension. In all subjects, there were significant increases in the levels of renin and angiotensin I, with reciprocal changes in angiotensin II, but no increase in the level of bradykinin. These changes were maximal at 90 minutes. In the patient, blood pressure fell in parallel with the angiotensin II levels. In the normotensive subjects, there was a significant diuresis and natriuresis after the administration of Captopril. Raised levels of circulating bradykinin, with potentiation after Captopril, were measured in an anaesthetized dog given exogenous bradykinin by infusion. These studies indicate that the hypotensive effect of Captopril is not due to raised circulating levels of bradykinin, and suggest a contribution by an intrarenal effect of the drug.Keywords
This publication has 12 references indexed in Scilit:
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor.Circulation Research, 1978
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Angiotensin I converting enzyme.Circulation Research, 1975
- Determination of blood kinin levels by radioimmunoassayBiochemical Pharmacology, 1972
- The radioimmunoassay of angiotensin IIProceedings of the Royal Society of London. B. Biological Sciences, 1969